Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
11,905
+78
+0.7% +$6.29K 0.23% 66
2026
Q1
$836K Buy
11,827
+217
+2% +$16.2K 0.21% 72
2025
Q4
$917K Buy
11,610
+336
+3% +$26.6K 0.22% 71
2025
Q3
$929K Buy
11,274
+27
+0.2% +$2.13K 0.25% 69
2025
Q2
$904K Sell
11,247
-461
-4% -$35.6K 0.25% 65
2025
Q1
$940K Sell
11,708
-74
-0.6% -$6.15K 0.27% 65
2024
Q4
$965K Sell
11,782
-92
-0.8% -$7.66K 0.28% 58
2024
Q3
$979K Buy
11,874
+101
+0.9% +$7.54K 0.29% 59
2024
Q2
$826K Buy
11,773
+499
+4% +$35.6K 0.26% 68
2024
Q1
$836K Buy
11,274
+334
+3% +$23.3K 0.28% 69
2023
Q4
$723K Buy
10,940
+423
+4% +$26.5K 0.25% 75
2023
Q3
$662K Buy
10,517
+2
+0% +$125 0.25% 81
2023
Q2
$594K Buy
10,515
+184
+2% +$10.2K 0.24% 79
2023
Q1
$599K Buy
10,331
+106
+1% +$7.15K 0.25% 79
2022
Q4
$740K Sell
10,225
-505
-5% -$36.2K 0.31% 68
2022
Q3
$652K Sell
10,730
-41
-0.4% -$2.62K 0.29% 68
2022
Q2
$676K Sell
10,771
-40
-0.4% -$2.65K 0.3% 68
2022
Q1
$723K Buy
10,811
+122
+1% +$8.25K 0.31% 67
2021
Q4
$668K Buy
10,689
+154
+1% +$9.66K 0.27% 82
2021
Q3
$650K Buy
10,535
+77
+0.7% +$4.64K 0.28% 80
2021
Q2
$626K Buy
10,458
+493
+5% +$31.2K 0.27% 80
2021
Q1
$606K Buy
+9,965
New +$550K 0.27% 82

Other funds holding MET

Navalign LLC's MET Position: Q2 2026 in Review

Navalign LLC increased its MetLife (MET) stake by 0.66% in Q2 2026, buying an estimated $6.29K and bringing the position to 11,905 shares worth $1.01M. The position accounts for 0.23% of the portfolio, ranked #66.

Navalign LLC first reported a position in MET in Q1 2021 and has held it in 22 quarters since. 865 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Navalign LLC held 11,905 shares of MetLife worth $1.01M as of Q2 2026.
  • Navalign LLC bought 78 MetLife shares in Q2 2026, an estimated $6.29K.
  • MetLife made up 0.23% of Navalign LLC's portfolio in Q2 2026, its #66 holding.
  • Navalign LLC first reported a position in MetLife in Q1 2021 and has held it in 22 quarters since.
  • 865 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.